ERNA - Eterna Therapeutics Inc.
0.285
-0.022 -7.719%
Share volume: 501,811
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.31
-0.02
-0.07%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 03-12-2025 | 05-07-2025 | 08-13-2025 | 11-07-2025 | |
| Total revenue | 1.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.000 K | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | nan% | |||
| Operating expenses | 2.698 M | 2.730 M | 2.501 M | 1.993 M | |
| Selling general and admin | 1.540 M | 1.421 M | 1.365 M | 958.000 K | |
| Research and development | 1.158 M | 1.309 M | 1.136 M | 1.035 M | |
| Total expenses | 2.698 M | 2.730 M | 2.501 M | 1.993 M | |
| 1.19% | -8.39% | -20.31% | |||
| Operating income | -2.697 M | -2.730 M | -2.501 M | -1.993 M | |
| Ebit | -2.072 M | -8.199 M | -3.136 M | -1.999 M | |
| Pretax income | -5.748 M | -8.194 M | -3.136 M | -1.234 M | |
| 42.55% | -61.73% | -60.65% | |||
| Income tax | 11.000 K | 8.000 K | 3.000 K | 6.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.759 M | -8.202 M | -3.139 M | -1.240 M | |
| -42.42% | 61.73% | 60.50% |